End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies

PC Egan, TW LeBlanc, AJ Olszewski - Blood Advances, 2020 - ashpublications.org
Patients with hematologic malignancies are thought to receive more aggressive end-of-life
(EOL) care and have suboptimal hospice use compared with patients with solid tumors, but …
被引用次数：27 相关文章

End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies

PC Egan, TW LeBlanc, AJ Olszewski - Blood advances, 2020 - pubmed.ncbi.nlm.nih.gov
Patients with hematologic malignancies are thought to receive more aggressive end-of-life
(EOL) care and have suboptimal hospice use compared with patients with solid tumors, but …

End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies

PC Egan, TW LeBlanc, AJ Olszewski - Blood Advances, 2020 - Elsevier
Patients with hematologic malignancies are thought to receive more aggressive end-of-life
(EOL) care and have suboptimal hospice use compared with patients with solid tumors, but …
[HTML] nih.gov

[HTML][HTML] End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies

PC Egan, TW LeBlanc, AJ Olszewski - Blood Advances, 2020 - ncbi.nlm.nih.gov
Patients with hematologic malignancies are thought to receive more aggressive end-of-life
(EOL) care and have suboptimal hospice use compared with patients with solid tumors, but …

End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies.

PC Egan, TW LeBlanc, AJ Olszewski - Blood Advances, 2020 - europepmc.org
Patients with hematologic malignancies are thought to receive more aggressive end-of-life
(EOL) care and have suboptimal hospice use compared with patients with solid tumors, but …